43
Participants
Start Date
May 24, 2021
Primary Completion Date
June 10, 2022
Study Completion Date
January 13, 2023
Lanreotide autogel
Administered as deep subcutaneous (SC) injections
Cancer Hospital Chinese Academy of Sciences, Beijing
Beijing Cancer Hospital, Beijing
Peking University Third Hospital, Beijing
Harbin Medical University Cancer Hospital, Harbin
Zhongshan Hospital Affiliated to Fudan University, Shanghai
Fudan University Shanghai Cancer Centre, Shanghai
Qilu Hospital Of Shandong University, Jinan
The second affiliated hospital of Zhejiang University School of Medicine, Hangzhou
The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou
West China Hospital of Sichuan University, Chengdu
The First Affiliated Hospital Of Xi'an Jiaotong University, Xi’an
Lead Sponsor
Ipsen
INDUSTRY